Company: STAA
Filing Date: 2025-09-16
Form Type: DEFM14A
Source: 0001193125-25-204396
Chunk: 119

Company: STAAR SURGICAL CO
Filing Date: 2025-09-16
Form: DEFM14A
Chunk 119
---
262 provides that fair value is to be “exclusive of any element of value arising
from the accomplishment or expectation of the merger.” InCede& Co.v. Technicolor, Inc., the Supreme Court of Delaware stated that such exclusion is a “narrow exclusion [that] does not encompass
known elements of value,” but which rather applies only to the speculative elements of value arising from such accomplishment or expectation. InWeinberger, the Supreme Court of Delaware also stated that “elements of future
value, including the nature of the enterprise, which are known or susceptible of proof as of the date of the merger and not the product of speculation, may be considered.”

Stockholders and beneficial owners considering seeking appraisal should be aware that the fair value of their shares of STAAR common stock as
so determined by the Delaware Court of Chancery could be more than, the same as or less than the consideration they would receive pursuant to the Merger if they did not seek appraisal of their shares of STAAR common stock and that an opinion of an
investment banking firm as to the fairness from a financial point of view of the consideration payable in a merger is not an opinion as to, and does not in any manner address, fair value under Section 262. Although STAAR believes that the
Merger Consideration is fair, no representation is made as to the outcome of the appraisal of fair value as determined by the Delaware Court of

-71-

Chancery, and stockholders and beneficial owners should recognize that such an appraisal could result in a determination of a value higher or lower than, or the same as, the Merger Consideration.
Neither STAAR nor Alcon anticipates offering more than the Merger Consideration to any person exercising appraisal rights. Each of STAAR and Alcon reserves the right to assert, in any appraisal proceeding, that for purposes of Section 262, the
“fair value” of a share of STAAR common stock is less than the Merger Consideration.

Unless the Delaware Court of Chancery in
its discretion determines otherwise for good cause shown, interest from the Effective Time through the date of payment of the judgment will be compounded quarterly and will accrue at 5% over the Federal Reserve discount rate (including any
surcharge) as established from time to time during the period between the Effective Time and the date of payment of the judgment; provided that if at any time before the Delaware Court of Chancery enters judgment in the appraisal proceeding,
the Surviving Corporation pays to each